0001723046-17-000001.txt : 20171208 0001723046-17-000001.hdr.sgml : 20171208 20171208095955 ACCESSION NUMBER: 0001723046-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171208 DATE AS OF CHANGE: 20171208 EFFECTIVENESS DATE: 20171208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Obsidian Therapeutics, Inc. CENTRAL INDEX KEY: 0001723046 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-300326 FILM NUMBER: 171246246 BUSINESS ADDRESS: STREET 1: 1030 MASSACHUSETTS AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 339-221-6090 MAIL ADDRESS: STREET 1: 1030 MASSACHUSETTS AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02138 D 1 primary_doc.xml X0708 D LIVE 0001723046 Obsidian Therapeutics, Inc. 1030 MASSACHUSETTS AVENUE SUITE 400 CAMBRIDGE MA MASSACHUSETTS 02138 339-364-6721 DELAWARE None None Corporation true 2015 Peter Barrett 1030 Massachusetts Avenue Suite 400 Cambridge MA MASSACHUSETTS 02138 Executive Officer Director Michael Gilman 1030 Massachusetts Avenue Suite 400 Cambridge MA MASSACHUSETTS 02138 Executive Officer Director Jason Gardner 1030 Massachusetts Avenue Suite 400 Cambridge MA MASSACHUSETTS 02138 Director Carolyn Ng 1030 Massachusetts Avenue Suite 400 Cambridge MA MASSACHUSETTS 02138 Director Karen Hong 1030 Massachusetts Avenue Suite 400 Cambridge MA MASSACHUSETTS 02138 Director David Neafus 1030 Massachusetts Avenue Suite 400 Cambridge MA MASSACHUSETTS 02138 Executive Officer Biotechnology Decline to Disclose 06b false 2017-11-29 true true false 0 49936323 32436323 17500000 false 8 0 0 0 false Obsidian Therapeutics, Inc. /s/Michael Gilman Michael Gilman President 2017-12-08